Steven S. Williamson

Steven S. Williamson

Chief Executive OfficeratPulmonx· In proxies 2021–2024

Pay in FY2024Pulmonx stock -46.7% the same year

Steven S. Williamson was paid $5.2M in FY2024 (Dec). Pulmonx stock fell 46.7% that year.

Pay$100 in the stock at the end of FY22 → $81
Pay is from the Summary Compensation Table of each Pulmonx proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PulmonxPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -67%
  2. Outset MedicalPublic company · 5 yr
    • Former Chief Commercial Officer2021 – Present · 5 yrNo stock prices for these years
  3. Tuvali Therapeutics, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?